Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results09/04/2024 majac Heart Disease Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results. by Bernice Lottering. Alnylam Pharmaceuticals’ shares fell 8.5 …Share on FacebookTweetFollow usSave